Skip to main content
All lobbying filings

DLA PIPER LLP (US)

Lobbying for BIOGEN, INC. · Biotechnology company.

 Filing Registration
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 1, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 3
  • RICHARD BURR Former member of Congress New on this filing
    Previously held: U.S. Senator
  • MARGARET MARTIN New on this filing
    Previously held: Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr
  • MICHAEL SORENSEN New on this filing
    Previously held: Scheduler and other positions, Sen. Richard Burr; Intern, Rep. John Boehner; Intern, Rep. Mike Kelly

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 2
Medical/Disease Research/Clinical Labs

Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.

Health Issues

Federal proposals and policies impacting disease treatment, including: health care policies; Medicare and Medicaid payment, coverage, and reimbursement; drug pricing and supply chain issues; FDA policies and procedures; drug patents and patent reporting requirements; tariffs; tax reform and tax policy; and intellectual property protections and enforcement.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem